Citations

Clear

1320 citation(s) found for "Nguyen, Vi".

Do Patients Die from Rashes from Epidermal Growth Factor Receptor Inhibitors? A Systematic Review to Help Counsel Patients About Holding Therapy
Jatoi, Aminah , Nguyen, Phuong

Mayo Clinic

The Oncologist | November 7, 2008 | Volume: 13 | Issue: 11 | Pages: 1201-1204

10.1634/theoncologist.2008-0149 | PMID 18988655 Get It

Abstract Rash from epidermal growth factor receptor inhibitors is common and negatively impacts the quality of life of cancer patients. Published guidelines recommend holding cancer therapy if the rash is severe. Does this recommendation hinge solely on improving patients' quality of life, or does it also hinge on the prevention of a potentially fatal, cutaneous adverse event? In other words, do patients die from rashes from epidermal growth factor receptor inhibitors? To our knowledge, the latter question has never before been asked and answered in an evidence-based fashion. Therefore, we conducted a systematic review of the published, prospectively conducted clinical trial literature on epidermal growth factor receptor inhibitors. The primary aim was to determine whether rash-related death has ever been reported in such trials. Among 117 such trials, which included 8,998 cancer patients, the rate of rash development was >50%, as expected. However, there were no reported deaths from a rash. Although we cannot conclude that a rash-related death from this class of agents can never occur, this systematic review provides evidence-based guidance on how best to counsel cancer patients who develop a rash from an epidermal growth factor receptor inhibitor. It suggests that quality of life issues should remain at the forefront as cancer patients and health care providers make decisions about holding cancer therapy.
Applications of SPECT/CT in Nuclear Radiology
Roarke, Michael C., Pockaj, Barbara A. , Nguyen, Ba D.

Mayo Clinic

American Journal of Roentgenology | August 20, 2008 | Volume: 191 | Issue: 3 | Pages: W135-W150

10.2214/ajr.07.3564 | PMID 18716081 Get It

In Vitro Activity of Anidulafungin against Candida albicans Biofilms
Jacobson, Melissa, Piper, Kerryl E., Nguyen, Gary, Steckelberg, James M., Patel, Robin , Patel, Robin

Mayo Clinic

Antimicrobial Agents and Chemotherapy | April 7, 2008 | Volume: 52 | Issue: 6 | Pages: 2242-2243

10.1128/aac.00211-08 | PMID 18391031 Get It

ABSTRACT We tested the activity of anidulafungin against 30 Candida albicans isolates. The planktonic MICs for 50 and 90% of the isolates tested (MIC 50 and MIC 90 ) were ≤0.03 and 0.125 μg/ml, respectively (MIC range, ≤0.03 to 2 μg/ml). The sessile MIC 50 and MIC 90 were ≤0.03 and ≤0.03 μg/ml, respectively (MIC range, ≤0.03 to >16 μg/ml).
AJR Teaching File: Nuclear Imaging of a Tender Skull Mass
McNaughton, Dean Alexander, Nguyen, Ba D.

Mayo Clinic

American Journal of Roentgenology | November 20, 2007 | Volume: 189 | Issue: 6_supplement | Pages: S61-S63

10.2214/ajr.07.7029 | PMID 18029904 Get It

Double-Blind, Randomized Trial of an Anti-CD18 Antibody in Conjunction With Recombinant Tissue Plasminogen Activator for Acute Myocardial Infarction
Baran, Kenneth W., Nguyen, Michel, McKendall, George R., Lambrew, Costas T., Dykstra, Gary, Palmeri, Sebastian T., Borzak, Steven, Sobel, Burton E., Gourlay, Steven G. , Rundle, Amy Chen, Barron, Hal V., Gibbons, Raymond J. , Gibson, C. Michael

Mayo Clinic

Circulation | September 28, 2007 | Volume: 104 | Issue: 23 | Pages: 2778-2783

10.1161/hc4801.100236 | PMID 11733394 Get It

Background Inhibition of leukocyte adhesion can reduce myocardial infarct size in animals. This study was designed to define the safety and efficacy of a recombinant, humanized, monoclonal antibody to the CD18 subunit of the β2 integrin adhesion receptors (rhuMAb CD18), in reducing infarct size in patients treated with a thrombolytic agent. Methods and Results The Limitation of Myocardial Infarction following Thrombolysis in Acute Myocardial Infarction Study (LIMIT AMI) was a randomized, double-blind, placebo-controlled, multicenter study conducted in 60 centers in the United States and Canada. A total of 394 subjects who presented within 12 hours of symptom onset with ECG findings (ST-segment elevation) consistent with AMI were treated with recombinant tissue plasminogen activator and were also given an intravenous bolus of 0.5 or 2.0 mg/kg rhuMAb CD18 or placebo. Coronary angiography was performed at 90 minutes, 12-lead ECGs were obtained at baseline, 90, and 180 minutes, and resting sestamibi scans were performed at ≥120 hours. Adjunctive angioplasty and use of glycoprotein IIb/IIIa antiplatelet agents at the time of angiography were discretionary. There were no treatment effects on coronary blood flow, infarct size, or the rate of ECG ST-segment elevation resolution, despite the expected induction of peripheral leukocytosis. A slight trend toward an increase in bacterial infections was observed with rhuMAb CD18 ( P =0.33). Conclusions RhuMAb CD18 was well tolerated but not effective in modifying cardiac end points.
AJR Teaching File: Dyspnea Following Surgical Repair of Partial Anomalous Venous Return
Nguyen, Ba D.

Mayo Clinic

American Journal of Roentgenology | August 22, 2007 | Volume: 189 | Issue: 3_supplement | Pages: S26-S28

10.2214/ajr.06.0569 | PMID 17715073 Get It

AJR Teaching File: Multiple Symmetric Abnormalities in a Radionuclide Bone Scan
Ram, Panol C., Nguyen, Ba D.

Mayo Clinic

American Journal of Roentgenology | August 22, 2007 | Volume: 189 | Issue: 3_supplement | Pages: S32-S34

10.2214/ajr.06.0568 | PMID 17715075 Get It

AJR Teaching File: Cavitated Mass with Hypertrophic Osteoarthropathy
McNaughton, Dean Alexander, Nguyen, Ba D.

Mayo Clinic

American Journal of Roentgenology | February 20, 2007 | Volume: 188 | Issue: 3_supplement | Pages: S7-S9

10.2214/ajr.06.0150 | PMID 17312084 Get It

Vitamin D–Resistant Rickets and Type 1 Diabetes in a Child With Compound Heterozygous Mutations of the Vitamin D Receptor (L263R and R391S): Dissociated Responses of the CYP-24 and rel-B Promoters to 1,25-Dihydroxyvitamin D3
d’Alésio, Arnold, Pascussi, Jean‐Marc , Kumar, Rajiv , Griffin, Matthew D. , Dong, Xiangyang , Guillozo, H., Rizk‐Rabin, Marthe , Sinding, Christiane, Bougnères, Pierre , Jehan, Frédéric, Garabédian, Michèle, Nguyen, Tuan M. , Griffin, Matthew D , Kumar, Rajiv

Mayo Clinic

Journal of Bone and Mineral Research | June 5, 2006 | Volume: 21 | Issue: 6 | Pages: 886-894

10.1359/jbmr.060307 | PMID 16753019 Get It

Abstract We report here the first association between vitamin D–resistant rickets, alopecia, and type 1 diabetes in a child with compound heterozygous mutations in the VDR gene. Transfection studies suggest dissociated effects of VDR gene mutations on the regulation of genes involved in vitamin D metabolism and dendritic cell maturation. Introduction: Whereas vitamin D may play a role in the immune tolerance process, no patient has been reported to associate hereditary vitamin D–resistant rickets (HVDRR) and an autoimmune disease, and no attempt has been made to delineate the outcome of mutations of the vitamin D receptor (VDR) on the transcription of genes controlling immune tolerance. Materials and Methods: The VDR gene was analyzed in a child with vitamin D–resistant rickets, total alopecia, and early childhood–onset type 1 diabetes. Patient's fibroblasts and COS-7 cells transfected with wildtype or mutant VDRs were studied for ligand-binding capacity, transactivation activity using two gene promoters [CYP-24, a classical 1,25(OH)2D3-responsive gene, and relB, a critical NF-κB component for regulation of dendritic cell differentiation], VDR-RXR heterodimers association to CYP 24 VDREs by gel mobility shift assays, and co-activator binding by Glutathione-S-transferase pull-down assays. Results: Two novel compound heterozygous mutations (L263R and R391S) were identified in the VDR ligand-binding domain in this child. Both mutations significantly impaired VDR ligand-binding capacity but had dissociated effects on CYP-24 and RelB promoter responses to vitamin D. CYP 24 response binding to SRC-1 and RXR-heterodimer binding to CYP24 VDREs were abolished in L263R mutants but normal or partially altered in R391S mutants. In the opposite, RelB responses to vitamin D were close to normal in L263R mutants but abolished in R391S mutants. Conclusions: We report the first clinical association between HVDRR, total alopecia, and early childhood–onset type 1 diabetes. Mutations in the VDR ligand-binding domain may hamper the 1,25(OH)2D3–mediated relB responses, an effect that depends on the site of the VDR mutation and cannot be anticipated from VDR ligand-binding ability or CYP-24 response. Based on these results, we propose to survey the immune function in patients with HVDRR, including those with moderate features of rickets.
Fractures After Thyroidectomy in Men: A Population-Based Cohort Study
Nguyen, Tu T., Heath, Hunter, Bryant, Sandra C. , O'Fallon, W. Michael, Melton, L. Joseph

Mayo Clinic

Journal of Bone and Mineral Research | April 26, 2006 | Volume: 12 | Issue: 7 | Pages: 1092-1099

10.1359/jbmr.1997.12.7.1092 | PMID 9200009 Get It

Abstract Bone mass is purportedly reduced by an endogenous or exogenous excess of thyroid hormone or, perhaps, by calcitonin deficiency. Patients who have undergone thyroidectomy could be subject to all of these effects, yet their practical implications in terms of fracture risk are poorly defined. Interpretation is further hampered by the focus on women, where results may be influenced by involutional osteoporosis. Consequently, we assessed the potential for fractures among the 136 Rochester, Minnesota men who underwent thyroidectomy between 1935 and 1979, relative to a group of age-matched control men from the community. With 2194 person-years of follow-up in each group, survival free of any fracture of vertebra, proximal humerus, distal forearm, pelvis, or proximal femur was similar in the two groups (p = 0.23), and the relative risk of any of these fractures for thyroidectomized patients versus their controls was increased only 1.5-fold (95% CI, 0.7–3.2). The difference was entirely accounted for by a statistically significant excess of proximal femur fractures in the men with thyroidectomy. Risk factors for fractures among men with thyroidectomy included greater age at surgery, greater extent of surgery, and the presence of risk factors for secondary osteoporosis. Thus, thyroidectomy, performed mainly for adenoma or goiter, seems to have little overall influence on the risk of age-related fractures in men. However, the association with hip fractures requires further evaluation.